中国上海两个前瞻性队列中从不吸烟者肺癌的全表观基因组关联研究
在上海女性健康研究与上海男性健康研究中,对80例从不吸烟的肺癌病例和83例对照进行巢式病例对照研究,采用诊断前口腔漱液样本检测DNA甲基化。全表观基因组关联分析发现3个与肺癌显著相关的差异甲基化位点,GrimAge加速为肺癌危险因素(OR=1.19/年;95%CI 1.06至1.34)。
要点
- 诊断前口腔漱液DNA甲基化或可提示从不吸烟者肺癌风险
- cg09198866(MYH9;TXN2)、cg01411366(SLC9A10)和cg12787323达全表观基因组显著水平
- GrimAge加速每年与肺癌风险OR=1.19相关
核心结论
- 诊断前口腔漱液DNA甲基化模式可能为从不吸烟者肺癌机制提供新线索,但需更大样本重复验证。
研究设计与样本
- 上海女性健康研究与上海男性健康研究内的巢式病例对照研究,纳入80例从不吸烟的肺癌病例和83例从不吸烟对照。
- 采用Illumina MethylationEPIC阵列检测诊断前口腔漱液样本DNA甲基化。
- 发现样本101人进行EWAS,前50个DMP在62人重复样本中评估,采用固定效应荟萃分析合并结果。
主要发现
- 在全表观基因组显著性水平p<8.22×10-8下识别出3个与肺癌显著相关的DMP:cg09198866(MYH9;TXN2)、cg01411366(SLC9A10)和cg12787323。
- 前1000个DMP在上皮调控区域显著富集,并涉及小GTP酶介导的信号转导通路。
- GrimAge加速为肺癌危险因素(OR=1.19每年;95%CI 1.06至1.34)。
关键数值与推荐
- 全表观基因组显著性阈值为p<8.22×10-8。
- GrimAge加速每年与肺癌风险的OR=1.19(95%CI 1.06至1.34)。
临床怎么用
- 对从不吸烟者,可关注口腔漱液DNA甲基化标志物及GrimAge加速作为风险分层线索,但尚不能直接用于临床筛查。
局限性
- 结论需在更大样本中重复验证。
- 既往EWAS多聚焦外周血DNA甲基化且从不吸烟者代表性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aetiology of lung cancer among individuals who never smoked remains elusive, despite 15% of lung cancer cases in men and 53% in women worldwide being unrelated to smoking. Epigenetic alterations, particularly DNA methylation (DNAm) changes, have emerged as potential drivers. Yet, few prospective epigenome-wide association studies (EWAS), primarily focusing on peripheral blood DNAm with limited representation of never smokers, have been conducted. METHODS: We conducted a nested case-control study of 80 never-smoking incident lung cancer cases and 83 never-smoking controls within the Shanghai Women's Health Study and Shanghai Men's Health Study. DNAm was measured in prediagnostic oral rinse samples using Illumina MethylationEPIC array. Initially, we conducted an EWAS to identify differentially methylated positions (DMPs) associated with lung cancer in the discovery sample of 101 subjects. The top 50 DMPs were further evaluated in a replication sample of 62 subjects, and results were pooled using fixed-effect meta-analysis. RESULTS: Our study identified three DMPs significantly associated with lung cancer at the epigenome-wide significance level of p<8.22×10-8. These DMPs were identified as cg09198866 (MYH9; TXN2), cg01411366 (SLC9A10) and cg12787323. Furthermore, examination of the top 1000 DMPs indicated significant enrichment in epithelial regulatory regions and their involvement in small GTPase-mediated signal transduction pathways. Additionally, GrimAge acceleration was identified as a risk factor for lung cancer (OR=1.19 per year; 95% CI 1.06 to 1.34). CONCLUSIONS: While replication in a larger sample size is necessary, our findings suggest that DNAm patterns in prediagnostic oral rinse samples could provide novel insights into the underlying mechanisms of lung cancer in never smokers.
引用
- Rahman ML, Breeze CE, Shu XO, et al. Epigenome-wide association study of lung cancer among never smokers in two prospective cohorts in Shanghai, China. Thorax. 2024. PMID: 38702190. doi:10.1136/thorax-2023-220352
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。